Erdafitinib is a targeted therapy for specific gene mutations (such as FGFR), primarily used to treat locally advanced or metastatic urothelial carcinoma. Its price is significantly affected by specifications, dosage, purchase channels, and medical insurance policies. The following is a detailed explanation:
I. Price Range
Domestic Market Price:
The price per box (usually containing 28 tablets) ranges from RMB 10,000 to 20,000, varying depending on the dosage (e.g., 40mg or 30mg) and regional differences.
Imported original drugs are more expensive, reaching RMB 20,000 to 30,000 per box; domestically produced generic drugs are cheaper, around several thousand RMB (note that generic drugs must be purchased through legitimate channels).
Medical Insurance Reimbursement:
Erdafitinib is included in the medical insurance catalogs of some provinces and cities, with a reimbursement rate of approximately 50%-70%, but this requires meeting the indications (e.g., positive FGFR gene test) and medical insurance restrictions.
II. Factors Affecting Price
Dosage and Treatment Duration:
The initial treatment dose is usually 8 mg daily, adjusted to 6 mg based on side effects. Long-term use will increase the total cost.
Purchase Channels:
Prices may vary at hospital pharmacies, designated pharmacies, or online platforms (such as those covered by medical insurance). It is recommended to obtain medication through a legitimate medical institution.
Regional Policies:
Some cities offer additional subsidies or charitable drug donation programs for specific cancer drugs, which can further reduce costs.
III. Precautions for Medication Use
Prescription Drug Regulations:
Erdatinib is a prescription drug and must be used under the guidance of a doctor. Do not purchase or adjust the dosage yourself.
Necessity of Genetic Testing:
FGFR gene testing is required before starting medication to confirm the indication and avoid ineffective treatment.
Side Effect Management:
Common side effects include hyperphosphatemia and oral ulcers. Regular monitoring and communication with the doctor to adjust the treatment plan are necessary.
IV. Medical Treatment and Cost Support Recommendations
Consult your attending physician: Understand local medical insurance policies and charitable programs (such as patient assistance programs).
Price comparison across multiple platforms: Obtain price information through hospitals, compliant pharmacies, and official channels.
Follow-up and re-examination: Regularly assess treatment effectiveness to avoid increased financial burden due to ineffective medication.
For specific price information, it is recommended to consult a hospital or designated medical insurance institution with your prescription and diagnosis certificate.
